Receptor Mechanisms Mediating Non-Genomic Actions of Sex Steroids

Viroj Boonyaratanakornkit; Dean P. Edwards

doi:10.1055/s-2007-973427

Seminars in Reproductive Medicine, Table of Contents

Semin Reprod Med 2007; 25(3): 139-153
DOI: 10.1055/s-2007-973427

Receptor Mechanisms Mediating Non-Genomic Actions of Sex Steroids

Viroj Boonyaratanakornkit¹ , Dean P. Edwards¹ ^, ²

¹Department of Molecular and Cellular Biology, Houston, Texas
²Pathology, Baylor College of Medicine, Houston, Texas

Abstract

ABSTRACT

Sex steroid hormones, including estrogen, progesterone, and androgen, mediate their biological effects on cell proliferation, differentiation, and homeostasis through their respective nuclear receptors. In addition to functioning as ligand-activated nuclear transcription factors to regulate gene transcription, these receptors also have been shown to mediate rapid activation of non-genomic signaling pathways independent of their transcriptional activity. Despite the fact that non-genomic effects of sex steroids have been observed since more than three decades ago, the receptor mechanisms mediating these rapid effects still are not well understood. A subpopulation of nuclear steroid receptors localized to the cell membrane or cytoplasm has been proposed to mediate steroid hormone activation of signaling pathways; however, novel membrane receptors unrelated to nuclear receptors have also been implicated. This review focuses on recent advances in our understanding of the nature of the receptors and mechanisms responsible for rapid non-genomic signaling actions of sex steroids, including novel membrane receptors and interactions of nuclear steroid receptors with membrane and cytoplasmic signaling molecules such as adapter proteins, G proteins, ion channels, and protein kinases. A better definition of receptor mechanisms involved in mediating activation of non-genomic signaling pathways is important to our overall understanding of the biology of steroid hormones.

KEYWORDS

Estrogen receptor - progesterone receptor - androgen receptor - non-genomic action - signal transduction

Full Text

References

REFERENCES

1 Mangelsdorf D J, Tummel C, Beato M et al.. The nuclear receptor superfamily: the second decade. Cell. 1995; 83 835-839
2 Tsai M, O'Malley B. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem. 1994; 63 451-486
3 McKenna N J, Lanz R B, O'Malley B W. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev. 1999; 20(3) 321-344
4 Ahrens-Fath I, Politz O, Geserick C, Haendler B. Androgen receptor function is modulated by the tissue-specific AR45 variant. FEBS J. 2005; 272 74-84
5 Kuiper G GJM, Enmark E, Pelto H-M, Nilsson S, Gustafsson J-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA. 1996; 93 5925-5930
6 Cowley S M, Parker M G. A comparison of transcriptional activation by ERa and ERb. J Steroid Biochem Mol Biol. 1999; 69 165-175
7 Hall J M, McDonnell D P. The estrogen receptor-b isoform (ERb) of the human estrogen receptor modulates ERa transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology. 1999; 140(12) 5566-5578
8 McInerney E M, Weis K E, Sun J, Mosselman S, Katzenellenbogen B S. Transcriptional activation by the human estrogen receptor subtype b (ERb) studies with ERb and ERa receptor chimeras. Endocrinology. 1998; 139(11) 4513-4522
9 Kastner P, Krust A, Turcotte B et al.. Two distinct estrogen-regulated promoters generate transcripts encoding two functionally different human progesterone receptor forms A and B. EMBO J. 1990; 9 1603-1614
10 Edwards D P. Progesterone receptor structure/function and crosstalk with cellular signaling pathways. In: Henry HL, Norman AW Encyclopedia of Hormones. San Diego, CA; Academic Press 2004
11 Giangrande P H, McDonnell D P. The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene. Recent Prog Horm Res. 1999; 54 291-313
12 Li X, O'Malley B W. Unfolding the action of progesterone receptor. J Biol Chem. 2003; 278 39261-39264
13 Baulieu E E. Cell membrane a target for steroid hormone. Mol Cell Endocrinol. 1978; 12 247-254
14 Benten W P, Lieberherr M, Sekeris C E, Wunderlich F. Testosterone induces Ca2 + influx via non-genomic surface receptors in activated T cells. FEBS Lett. 1997; 407 211-214
15 Pietras R J, Szego C M. Specific binding sites of estrogen at the outer surface of isolated endometrial cells. Nature. 1977; 265 69-72
16 Falkenstein E, Norman A W, Wehling M. Mannheim classification of non genomically initiated (rapid) steroid action(s). J Clin Endocrinol Metab. 2000; 85 2071-2075
17 Simoncini T, Genazzani A R. Non-genomic actions of sex steroid hormones. Eur J Endocrinol. 2003; 148 281-292
18 Bjornstrom L, Sjoberg M. Signal transducers and activator of transcription as downstream targets of nongenomic estrogen receptor actions. Mol Endocrinol. 2002; 16(10) 2202-2214
19 Duan R, Xie W, Burghardt R C, Safe S. Estrogen receptor-mediated activation of serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1. J Biol Chem. 2001; 276 11590-11598
20 Kousteni S, Bellido T, Plotkin L I et al.. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen recptors: dissociation from transcriptional activity. Cell. 2001; 104 719-730
21 Kousteni S, Chen J R, Bellido T et al.. Reversal of bone loss in mice by non-genotropic signaling of sex steroids. Science. 2002; 298 843-846
22 Pedram A, Razandi M, Aitkenhead M, Hughes C W, Levin E R. Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J Biol Chem. 2002; 277(52) 50768-50775
23 Zheng F F, Wu R-C, Smith C L, O'Malley B W. Rapid estrogen-induced phosphorylation of the SRC-3 coactivator occurs in an extranuclear complex containing estrogen receptor. Mol Cell Biol. 2005; 25 8273-8284
24 Zhu Y, Rice C D, Pang Y, Pace M, Thomas P. Cloning, expression and characterization of a novel membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci USA. 2003; 100 2231-2236
25 Zhu Y, Bond J, Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA. 2003; 100(5) 2237-2242
26 Karteris E, Zervou S, Pang Y et al.. Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term. Mol Endocrinol. 2006; 20 1519-1534
27 Krietsch T, Fernandes M S, Kero J et al.. Human homologs of the putative G protein-couple membrane progestin receptors (mPRα, β, γ) localize to the endoplasmic reticulum and are not activated by progesterone. Mol Endocrinol. 2006; 20 3146-3164
28 Revankar C M, Cimino D F, Sklar L A, Arterburn J B, Prossnitz E R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005; 307 1625-1630
29 Thomas P, Pang Y, Filardo E J, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005; 146 624-632
30 Filardo E J, Quinn J A, Bland K I, Frackelton A RJ. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via transactivation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol. 2000; 14 1649-1660
31 Filardo E J, Quinn J A, Frackelton A RJ, Bland K I. Estrogen action via the G protein-coupled receptor, GPR30: Stimulation of adenylyl cyclase and cAMP-mediated attenuation of epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol. 2002; 16 70-84
32 Maggiolini M, Vivacqua A, Fasanella G et al.. The G protein-coupled receptor GPR30 mediates c-fos up-regualtion by 17β-estradiol and phytoestrogens in breast cancer cells. J Biol Chem. 2004; 279 27008-27016
33 Pedram A, Razandi M, Levin E R. Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol. 2006; 20 1996-2009
34 Ahola T M, Manninen T, Alokio N, Ylikomi T. G protein-coupled receptor 30 is critical for a progestin-induced growth inhibition in MCF-7 breast cancer cells. Endocrinology. 2002; 143(9) 3376-3384
35 Bologa C G, Revankar C M, Young S M et al.. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol. 2006; 2 207-212
36 Figueroa-Valverde L, Luna H, Castillo-Henkel C, Munoz-Gracia O, Morato-Cartagena T, Ceballos-Reyes G. Synthesis and evaluation of the cardiovascular effects of two, membrane impermeant macromolecular complexes of dextran-testosterone. Steroids. 2002; 67 611-619
37 Kampa M, Papakonstanti E A, Hotzoglou A, Stathopoulos E N, Stournaras C, Castanas E. The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton. FASEB J. 2002; 16 1429-1431
38 Kampa M, Nifi A P, Charalampopoulos I et al.. Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis. Exp Cell Res. 2005; 307 41-51
39 Armen T A, Gay C V. Simultaneous detection and functional response of testosterone and estradiol receptors in osteoblast plasma membranes. J Cell Biochem. 2000; 79 620-627
40 Guo Z, Benten W P, Krucken J, Wunderlich F. Nongenomic testosterone calcium signaling. Genotropic actions in androgen receptor-free macrophages. J Biol Chem. 2002; 277 29600-29607
41 Benten W P, Lieberherr M, Giese G et al.. Functional testosterone receptors in plasma membranes of T cells. FASEB J. 1999; 13 123-133
42 Papakonstanti E A, Marilena K, Castanas E, Stournaras C. A rapid, nongenomic, signaling pathway regulates the actin reorganization induced by activation of membrane testosterone receptors. Mol Endocrinol. 2003; 17(5) 870-881
43 Srivastava A K, Dey S B, Roy S K. Interaction of cyproterone acetate with sex hormone binding globulin of monkey plasma. Exp Clin Endocrinol. 1983; 82 232-234
44 Nakhla A M, Leonard J, Hryb D J, Rosner W. Sex hormone binding globulin receptor signal transduction proceeds via a G-protein. Steroids. 1999; 64 213-216
45 Nakhla A M, Romas N A, Rosner W. Estradiol activates the prostate androgen receptor and prostate-specific antigen secretion through the intermediacy of sex hormone-binding globulin. J Biol Chem. 1997; 272 6838-6841
46 Levin E R. Cellular functions of plasma membrane estrogen receptors. Steroids. 2002; 67 471-475
47 Pappas T C, Gametchu B, Watson C S. Membrane estrogen receptor identified by multiple labeling and impeded-ligand binding. FASEB J. 1995; 9 404-410
48 Sabeur K, Edwards D P, Meizel S. Human sperm plasma membrane progesterone receptor(s) and the acrosome reaction. Biol Reprod. 1996; 54 993-1001
49 Song R X, Barnes C J, Zhang Z, Bao Y, Kumar R, Santen R J. The role of Shc and insulin-like growth factor I receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc Natl Acad Sci USA. 2004; 101 2076-2081
50 Song R X-D, McPherson R A, Adam L et al.. Linkage of rapid estrogen action to MAPK activation of ERa-Shc association and Shc pathway activation. Mol Endocrinol. 2002; 16 116-127
51 Razandi M, Pedram A, Greene G L, Levin E R. Cell membrane and nuclear estrogen receptors drive from a single transcript: studies of ERa and ERb expressed in CHO cells. Mol Endocrinol. 1999; 13 307-319
52 Razandi M, Oh P, Pedram A, Schnitzer J, Levin E R. ERs associates with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol. 2002; 16(1) 100-115
53 Rai D, Frolova A, Frasor J, Carpenter A E, Katzenellenbogen B S. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells. Mol Endocrinol. 2005; 19 1606-1617
54 Razandi M, Pedram A, Merchenthaler I, Greene G L, Levin E R. Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol. 2004; 18 2854-2865
55 Abraham I M, Todman M G, Korach K S, Herbison A E. Critical in vivo roles for classical estrogen receptors in rapid estrogen actions on intracellular signaling in mouse brain. Endocrinology. 2004; 145 3055-3061
56 Evinger A JI, Levin E R. Requirement for estrogen receptor α membrane localization and function. Steroids. 2005; 70 361-363
57 Razandi M, Alton G, Pedram A, Ghonshani S, Webb P, Levin E R. Identification of structural determinant necessary for the localization and function of estrogen receptor a at the plasma membrane. Mol Cell Biol. 2003; 23(5) 1633-1646
58 Li L, Haynes M P, Bender J R. Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA. 2003; 100 4807-4812
59 Marquez D C, Pictras R J. Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene. 2001; 2001(20) 5420-5430
60 Hammes S R. Steroid and oocyte maturation-a new look at an old story. Mol Endocrinol. 2004; 18 769-775
61 Maller J L. The elusive progesterone receptor in Xenopus oocytes. Proc Natl Acad Sci USA. 2001; 98 8-10
62 Bayaa M, Booth R A, Sheng Y, Liu X J. The classical progesterone receptor mediates Xenopus oocyte maturation through a nongenomic mechanism. Proc Natl Acad Sci USA. 2000; 97 12607-12612
63 Tian J, Kim S, Heilig E, Ruderman J V. Identification of XPR-1, a progesterone receptor required for Xenopus oocyte activation. Proc Natl Acad Sci USA. 2000; 97 14358-14363
64 Bagowski C P, Myers J W, Ferrell Jr J E. The classical progesterone receptor associates with p42 MAPK and is involved in phosphatidylinositol 3-kinase signaling in Xenopus oocytes. J Biol Chem. 2001; 276(40) 37708-37714
65 Lutz L B, Cole M K, Gupta K W, Kwist R J, Auchus R J, Hammes S R. Evidence that androgens are the primary steroids produced by Xenopus laevis ovaries and may signal through the classical androgen receptor to promote oocyte maturation. Proc Natl Acad Sci USA. 2001; 98 13728-13733
66 Lutz L B, Jamnonjit M, Yang W-H, Jahani D, Gill A, Hammes S R. Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands. Mol Endocrinol. 2003; 17 1106-1116
67 Gill A, Jamnonjit M, Hammes S R. Androgens promote maturation and signaling in mouse oocytes independent of transcription: a release of inhibition model for mammalian oocyte meiosis. Mol Endocrinol. 2004; 18 97-104
68 Mulholland D J, Dedhar S, Coetzee G A, Nelson C C. Interaction of nulcear receptors with the Wnt/β-catenin/Tcf axis: Wnt you like to know?. Endocr Rev. 2005; 26 898-915
69 Smart E J, Graft G A, McNiven M A et al.. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol. 1999; 19 7289-7304
70 Lu M L, Schneider M C, Zheng Y, Zhang X, Richie J P. Caveolin-1 interact with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem. 2001; 276 13442-13451
71 Schlegel A, Wang C, Katzenellenbogen B S, Pestell R G, Lisanti M P. Caveolin-1 potentiates estrogen receptor alpha (ERα) signaling, caveolin-1 drives ligand-independent nuclear translocation and activation of ERα. J Biol Chem. 1999; 274 33551-33556
72 Salatino M, Beguelin W, Peters M G et al.. Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation. Oncogene. 2006; 25 7723-7739
73 Lu Q, Pallas D C, Surks H K, Baur W E, Mendelsohn M E, Karas R H. Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. Proc Natl Acad Sci USA. 2004; 101 17126-17131
74 Lee H, Park D S, Razani B, Russell R G, Lisanti M P. Caveolin mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 ( - / - ) null mice show mammary epithelial cell hyperplasia. Am J Pathol. 2002; 161 1357-1369
75 Li T, Sotgia F, Vuolo M et al.. Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor α-positive status. Am J Pathol. 2006; 168 1998-2013
76 Thompson T C, Timme T L, Li L, Goltsov A. Caveolin-1, a metastasis-related gene that promote cell survival in prostate cancer. Apoptosis. 1999; 4(4) 233-237
77 Kumar R, Wang R-A, Mazumdar A et al.. A naturally occurring MTA1 variant sequesters oestrogen receptor-a in the cytoplasm. Nature. 2002; 418 654-657
78 Mazumdar A, Wang R-A, Mishra S K et al.. Transcriptional repression of estrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol. 2001; 3 30-37
79 Gururaj A E, Singh R R, Rayala S K et al.. MTA1, a transcriptional activator of breast cancer amplified sequence 3. Proc Natl Acad Sci USA. 2006; 103 6670-6675
80 Sato K, Nagao T, Kakumoto M et al.. Adapter protein Shc is an isoform-specific direct activator of the tyrosine kinase c-Src. J Biol Chem. 2002; 277 29568-29576
81 Cabodi S, Moro L, Baj G et al.. p130Cas interacts with estrogen receptor α and modulates non-genomic estrogen signaling in breast cancer cells. J Cell Sci. 2004; 117 1603-1611
82 Vadlamudi R K, Wang A, Mazumdar A et al.. Molecular cloning and characterization of PELP-1, a novel human coregulator of estrogen receptor α. J Biol Chem. 2001; 276 38272-38279
83 Wong C-W, McNally C, Nickbarg E, Komm B S, Cheskis B J. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA. 2002; 99(23) 14783-14788
84 Barletta F, Wong C-W, McNally B S, Komm B S, Katzenellenbogen B S, Cheskis B J. Characterization of the interactions of estrogen receptor and MNAR in the activation of c-Src. Mol Endocrinol. 2004; 18 1096-1108
85 Unni E, Sun S, Nan B et al.. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Cancer Res. 2004; 64 7156-7168
86 Haas D, White S N, Lutz L B, Rasar M, Hammes S R. The modulator of nongenomic actions of estrogen receptor (MNAR) regulates transcription-independent androgen receptor-mediated signaling: Evidence that MNAR participates in G protein-regulated meiosis in Xenopus laevis oocytes. Mol Endocrinol. 2005; 19 2035-2046
87 Nakajima T, Kitazawa T, Hamada E, Hazama H, Omata M, Kurachi Y. 17β-estradiol inhibits the voltage-dependent L-type Ca²⁺currents in aortic smooth muscle cells. Eur J Pharmacol. 1995; 294 625-635
88 White R E, Darkow D J, Lang J L. Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism. Circ Res. 1995; 77 936-942
89 Valverde M A, Rojas P, Amigo J, Cosmelli D, Orio P, Bahamonde M I. Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit. Science. 1999; 285 1929-1931
90 Mendoza C, Soler A, Tesarik J. Non-genomic steroid action: independent targeting of a plasma membrane calcium channel and a tyrosine kinase. Biochem Biophys Res Commun. 1995; 210 518-523
91 Grosse B, Kachkache M, Le Mellay V, Lieberherr M. Membrane signaling and progesterone in female and male osteoblasts: involvement of intracellular Ca²⁺, inositol triphosphate and diacylglycerol, but not cAMP. J Cell Biochem. 2000; 79 334-345
92 Barbagallo M, Dominguez L J, Licata G, Shan J, Bing L, Karpinski E. Vascular effects of progesterone: role of cellular calcium regulation. Hypertension. 2001; 37 142-147
93 Le Mellay V, Grosse B, Lieberherr M. Phospholipase C beta and membrane action of calcitriol and estradiol. J Biol Chem. 1997; 272 11902-11907
94 Wyckoff M H, Chambliss K L, Mineo C et al.. Plasma membrane estrogen receptors are coupled to endothlial nitric-oxide synthase through Gai. J Biol Chem. 2001; 276 27071-27076
95 Razandi M, Pedram A, Park S T, Levin E R. Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem. 2003; 278 2701-2712
96 Kurebayashi J, Okubo S, Yamamoto Y, Sonoo H. Inhibition of HER1 signaling pathway enhances antitumor effect of endocrine therapy in breast cancer. Breast Cancer. 2004; 11 38-41
97 Grazzini E, Guillon G, Mouillac B, Zingg H H. Inhibition of oxytocin receptor function by direct binding of progesterone. Nature. 1998; 392 509-512
98 Heinlein C A, Chang C. The role of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol. 2002; 16 2181-2187
99 Sun Y-H, Gao X, Tang Y-J, Xu C-L, Wang L-H. Androgens induces increases intracelluar calcium via a G-protein-coupled receptor in LNCaP prostate cancer cells. J Androl. 2006; 27 671-678
100 Thomas S M, Brugge J S. Celluar functions regulated by Src family kinases. Annu Rev Cell Dev Biol. 1997; 13 513-609
101 Xu W, Doshi A, Lei M, Eck M J, Harrison S C. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol Cell. 1999; 3 629-638
102 Castoria G, Barone M V, Demenico M D et al.. Non-transcriptional action of estradiol and progestin triggers DNA synthesis. EMBO J. 1999; 18 2500-2510
103 Boonyaratanakornkit V, Scott M P, Ribon V et al.. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell. 2001; 8 269-280
104 Boonyaratanakornkit V, McGowan E J, Sherman L, Mancini M A, Cheskis B J, Edwards D P. The role of extra-nuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and cell cycle. Mol Endocrinol. 2006(November); 30 , (Epub ahead of print)
105 Lim C S, Baumann C T, Hutun H et al.. Differential localization and activity of the -A and -B forms of the human progesterone receptor using green fluorescent protein chimeras. Mol Endocrinol. 1999; 13 366-375
106 Ballare C, Uhrig M, Betchtold T et al.. Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells. Mol Cell Biol. 2003; 23 1994-2008
107 Proietti C, Salatino M, Rosemblit C et al.. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Mol Cell Biol. 2005; 25 4826-4840
108 Migliaccio A, Castoria G, Di Domenico M et al.. Steroid-induced androgen receptor-oestradiol receptor-β-Src complex triggers prostate cancer cell proliferation. EMBO J. 2000; 19 5406-5417
109 Migliaccio A, Domenico M D, Castoria G et al.. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. Cancer Res. 2005; 65 10585-10593
110 Migliaccio A, Domenico M D, Castoria G et al.. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO. 1996; 15 1292-1300
111 Endoh H, Sasaki H, Maruyama K et al.. Rapid activation of MAP kinase by estrogenin the bone cell line. Biochem Biophys Res Commun. 1997; 235 99-102
112 Bi R, Broutman G, Foy M R, Thompson R F, Baudry M. The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus. Proc Natl Acad Sci USA. 2000; 97 3602-3607
113 Di Domenico M, Castoria G, Bilancio A, Migliaccio A, Auricchio F. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res. 1996; 56 4516-4521
114 Nguyen T-V, Yao M, Pike C J. Androgen activates mitogen-activated protein kinase signaling: role in neuroprotection. J Neurochem. 2005; 94 1639-1651
115 Razandi M, Pedram A, Levin E R. Estrogen signals to the preservation of endothelial cell from and function. J Biol Chem. 2000; 275 38540-38546
116 Seval Y, Cakmak H, Kayisli U A, Arici A. Estrogen-mediate regulation of p38 mitogen-activated protein kinase in human endometrium. J Clin Endocrinol Metab. 2006; 91 2349-2357
117 Razandi M, Pedram A, Levin E R. Plasma membrane estrogen receptor signal to antiapoptosis in breast cancer. Mol Endocrinol. 2000; 14 1434-1447
118 Funaki M, Katagiri H, Inukai K, Kikuchi M, Asano T. Structure and function of phosphatidylinositol-3,4 kinase. Cell Signal. 2000; 12 135-142
119 Simoncini T, Hafezi-Moghadam A, Brazil D P, Ley K, Chin W W, Liao J K. Interaction of oestrogen receptor with the regulatory subunit of phosphotidylinositol-3-OH kinase. Nature. 2000; 407 538-541
120 Castoria G, Migliaccio A, Bilancio A et al.. PI3 kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 2001; 20 6050-6059
121 Haynes M P, Li L, Sinha D et al.. Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J Biol Chem. 2003; 278 2118-2123
122 Sun M, Yang L, Feldman R I et al.. Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85α, androgen receptor and Src. J Biol Chem. 2003; 278 42992-43000
123 Duan R, Xie W, Li X, McDougal A, Safe S. Estrogen regulation of c-fos gene expression through phosphotidylinositol-3-kinase dependent activation of serum response factor in MCF-7 breast cancer cells. Biochem Biophys Res Commun. 2002; 294 384-394
124 Chen Y H, Lee M J, Chang H H, Hung P F, Kao Y H. 17 beta-estradiol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor, extracellularly regulated kinase, and CCAAT/enhancer binding protein-alpha pathways. Endocrinology. 2006; 147 4496-4504
125 Faivre E, Skildum A, Pierson-Mullany L, Lange C A. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators. Steroids. 2005; 70 418-426
126 Faivre E J, Lange C A. Progesterone receptor upregulate Wnt-1 to induce EGFR-transactivation of c-Src dependent sustained activation of Erk 1/2 MAP kinase in breast cancer cells. Mol Cell Biol. 2006; 27 466-480
127 Saitoh M, Ohmichi M, Takahashi H et al.. Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB cascade in human breast cancer cells. Endocrinology. 2005; 146 4917-4925
128 Shah Y M, Rowan B G. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity. Mol Endocrinol. 2005; 19 732-748
129 Dutertre M, Smith C L. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains. Mol Endocrinol. 2003; 17 1296-1314
130 Wu R C, Qin J, Yi P et al.. Selective phosphorylations of the SRC-3/AIBI coactivator integrate genomic responses to multiple cellular signaling pathways. Mol Cell. 2004; 15 937-949
131 Harrington W R, Kim S H, Funk C C et al.. Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol Endocrinol. 2006; 20 491-502

Viroj BoonyaratanakornkitPh.D.

Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza

MS-130, Houston, TX 77030

Email: virojb@bcm.tmc.edu